LGLs have been well characterized as clonal LGL proliferations (LGL leukemia). In contrast, the clonal nature and clinical features of patients with CD3-LDGL have not been defined. In this study, we analyzed seven female patients with CD3-LDGL who were heterozygous at certain X-linked gene loci. Neutrophils and CD3-granular lymphocytes were isolated from peripheral blood. Clonal analysis was performed on genomic DNA from these cell fractions on six patients by conventional Southern techniques using probes to the X-linked genes, PGK and DXS255 (M278). In four HE LYMPHOPROLIFERATIVE disease of granular T lymphocytes (LDGL) results from a chronic proliferation of large granular lymphocytes (LGLs) that may have either a CD3+ or CD3-phenotype.'-' It is conceivable that LDGL could encompass both neoplastic or reactive condition~.',~ Most patients with a CD3+ LGL disorder have clonal rearrangements of the T-cell receptor (TCR) / 3 gene, supporting the designation in these cases of LGL l e~k e m i a .~-~ However, it is not possible to determine clonality in the CD3-LGL patients using TCR gene probes as CD3-LGLs do not rearrange TCR Therefore, it has not been well defined whether patients with CD3-LDGL have a clonal disorder.
T lymphocytes (LDGL) results from a chronic proliferation of large granular lymphocytes (LGLs) that may have either a CD3+ or CD3-phenotype.'-' It is conceivable that LDGL could encompass both neoplastic or reactive condition~.',~ Most patients with a CD3+ LGL disorder have clonal rearrangements of the T-cell receptor (TCR) / 3 gene, supporting the designation in these cases of LGL l e~k e m i a .~-~ However, it is not possible to determine clonality in the CD3-LGL patients using TCR gene probes as CD3-LGLs do not rearrange TCR Therefore, it has not been well defined whether patients with CD3-LDGL have a clonal disorder.
Clonal analysis of female cell populations heterozygous for markers on the X chromosome has been very informative about their nature and origins. Studies with the X-linked enzyme, glucose-6-phosphate dehydrogenase, demonstrated that neoplastic cell populations were derived from a single tumor stem cell? Analysis of clonality using genetic markers for the X chromosome is based on the random inactivation of one X chromosome in early embryogenesis and subsequent stable transmission to progeny. There is a limitation in the utilization of G6PD isoenzymes for clonal analysis because of its rarity in most ethnic groups. Studies with DNA probes to informative areas on the X chromosome allow the analysis of about 70% of females in the general population."." Restriction fragment length polymorphisms (RFLPs) at the phosphoglycerate kinase (PGK) loci on the X chromosome can distinguish between the maternal and paternal X chromosome in approximately 25% of the general female populations. A clonal analysis using this locus can be performed by a conventional Southern technique or by means of the PCR." The other informative region, involving a variable copy number tandem repeat (VNTR) on the X chromosome (DXS255) allows the analysis of approximately 60% of the general female population. The active and inactive X chromosomes are distinguished by their different methylation patterns that are detected by a methylation-sensitive restriction enzyme. Two populations of cells derived from different stem cell clones marked by the inactivation of either the maternal or paternal X chromosome can therefore be defined.
With the aim of determining whether patients with CD3-LDGL have a clonal disorder, we studied female patients patients, three of whom were already studied by Southern analyses of genomic DNA and one in whom there were insufficient amounts of DNA, polymerase chain reaction (PCR)-based clonal analysis was performed with primer pairs flanking the BstXl polymorphism on the PGK gene. In six patients, a polyclonal expansion of CD3-granular lymphocytes was demonstrated and in one the result was indeterminate. In contrast to patients with CD3+ LDGL (LGL leukemia), a clonal disease could not be demonstrated with X-linked markers in patients with CD3-LDGL, suggesting a reactive rather than a neoplastic origin of the lymphocytes in these cases. 0 1993 by The American Society of Hematology.
with CD3-LDGL who were also heterozygous for these Xlinked loci. Of seven patients in whom such analyses were informative, six patients showed a polyclonal pattern of Xchromosome inactivation and one patient was indeterminate.
MATERIALS AND METHODS
The clinical, hematologic, and serologic features of seven patients are summarized (Table I) . Each patient met criteria for LGL lymphoproliferative disorder, having sustained (>6 months) elevation of LCL counts > 2,000/pL3. None of the patients had a history of recurrent infections or rheumatoid arthritis, and none had splenomegaly on physical examination. Two patients had a history of chronic hepatitis, hepatitis C (patient no. 2) , and hepatitis B (patient no. 5). Three patients had mild neutropenia. There was no evidence of humoral immune abnormalities in any patient. Lymphocyte surface marker studies showed that there were increased percentages of cells bearing LGL markers, such as CD16 and CD57. The low percentage of cells bearing CD3 suggested that LGL antigens were on CD3-cells, which was confirmed by two-color flow cytometry analyses ( Table 2) .
Peripheral blood mononuclear cells (PBMCs) were first isolated from whole blood using Ficoll-Hypaque density gradient centrifugation (Pharmacia, Piscataway, NJ). These cells were subsequently analyzed for the presence of cell surface antigens using an EPIC cytofluorometer (Coulter, Hialeah, FL) Neutrophils were isolated by lysing the red blood cell pellet after Ficoll-Hypaque density gradient centrifugations. PBMCs were enriched for CD3-natural killer (NK) lymphocytes in patients nos. 1 to 3 , 5 , and 6, using a modification of a method previously described.14 The cell suspension was initially depleted of adherent cells by incubation for 45 minutes in plastic Petri dishes at 37°C in an atmosphere of 95% air and 5% C02.
LGLs were further purified by removing CD3' and CD19' lymphocytes using magnetic microspheres coated with anti-mouse IgG (Dynebeads, Dynal, Norway) according to the method already rep~rted.'~ Briefly, after incubation (45 minutes at 4°C) of the cell suspension obtained as above with CD3 (OKT3; Ortho, Raritan, NJ) and CD19 (Leu-12; Becton Dickinson) MoAbs, 40 X IO6 beads were incubated with 10 X lo6 cells/mL for 30 minutes at 4°C under continuous slow rotation. The CD3+ and CD19+ cells rosetting with antibody-coated beads were then isolated and removed applying a magnetic system on the outer wall of the test tubes for 2 minutes. Following this multistep negative selection procedure, more than 97% of the cells were viable when tested by the trypan blue exclusion test and were found to show LGL morphology. Different methodologies were used to enrich the CD3-LGLs in patients nos. 4 and 7. PBMCs from patient no. 4 were passaged over nylon wool columns and nylon wool nonadherent cells were then depleted of CD3+ cells by panning using a CD3-specific MoAb-coated plates.
The nonadherent CD3-population was contaminated by 1.4% T cells (CD3+), 1.8% B cells (CD19+), and 0.2% monocytes (CD14+), as determined by cytofluorometric analyses. PBMCs from patient no. 7 were enriched for NK and T cells with two-color sorting, using CD3-specific and CD 16-specific MoAbs. CD3-, CD I6+ sorted cells were >93% pure and CD3-CD16' sorted cells were >97% pure as determined by cytofluorometric reanalyses. High molecular weight DNA was isolated by subjecting cell fractions to lysis and digestion in 1% sodium dodecyl sulfate (SDS) and 200 &mL of proteinase K and incubating overnight at 37°C. DNA was precipitated in 0.5 vol of 7.5 mol/L ammonium acetate and 2 vol of ethanol. In the first method of clonal analysis, two multiple restriction enzyme digests were performed to determine if heterozygosity for a restriction site polymorphism was present. BsfXl and Psfl digests and Bgll, Bglll, and EcoRl digest were performed to confirm the presence of the BstXI and BglJ polymorphism on the PGK gene. The sample was divided into two portions, one half stored and the other half digested with Hpall. In the other method, MspI and PstI digests were performed to detect a VNTR on the X chromosomes with the M27@ DNA probe. An aliquot of the initial PstI digest was then digested with HpaII. Reaction conditions, electrophoresis, transfer to nitrocellulose, and hybridization were performed as des"ibed.'0.''.'6 DNA probes were an 800-bp BamHI/EcoRI fragment from the 5' end of the PGK gene cloned into the BamHI/EcoRI site of pSP64 (pSPTJPGK) and a M27@,2.3-kb EcoRI fragment cloned into pUC9. Probes were labeled by oligolabeling using [32P]deoxycytidine triphosphate." Autoradiography was performed for 1 to 5 days at -70°C with Kodak XAR-5 film (Kodak, Rochester, NY) and Dupont Lightning Plus intensifying screens (Dupont, Wilmington, DE). Digital imaging on a phosphorous imaging cassette (Molecular Dynamics 400A Phosphor Imager; SunClonal analysis.
For nyvale. CA) was also performed to allow for quantitativc densitometric analysis of signals.'R Comparisons of band intensities for detcrmination of clonal ratios were done as previously described.'' PCR-based clonal analysis was done using a modification of the technique described by Blanchard et a].'' For each sample tested, 100 ng of DNA was digested with Hpall in I X PCR buffer (TRIS 10 mmol/L. KCI 50 mmol/L, MgCI2 1.5 mmol/L, and gelatin 0.1%) at 37°C and added to a mix containing deoxyribonuclease triphosphate (dNTP). primers. additional buffer and Taq polymerase. A trace amount of [-'*P] deoxycytidine triphosphate (dCTP) (0. I pL of 3.000 Ci/mmol) was added to allow autoradiography of the reaction product. Total reaction volume was 60 pL and reaction conditions were an initial denaturation step of 95°C for 5 minutes followed by 40 cycles of the following: 95°C for I minute; 65°C for 2 minutes: 72°C for 3 minutes. PCR primers were selected to flank the BstXl polymorphism and six methylation sites (Fig I) . Primer pairs were P, CATTCTTCACGTCCGTTCGCAGCGT (upstream) and Pz AAGCTCTGCAGGCCTCCTCC or PI TACTCCTGAAGTTAAA-TCAACATCCKTTG (downstream). The PI-P2 primer combination generates a fragment of 1.054 bp and the Pl-P3 combination generates a fragment of 977 bp. The PI-BstXI fragment is 880 bp. PCR was performed on a Perkin Elmer thermal cycler.
One microliter of IOX high-salt restriction enzyme buffer and I pL of BsrXl (1O.OOO p/mL New England Biolabs. Beverly. MA) enzyme was added to 25 pL of the PCR reaction and restriction digested at 55°C. Samples were analyzed on a 2% agarose gel. initially by ethidium bromide staining and then by autoradiography of the drieddown gel. Digital imaging on a phosphorous imaging cassette was done to allow relative quantitation of the two allclic bands. A correction factor was applied to the densitometry reading of the lower allele to account for guanine-cytosine (G-C) content of the digested fragment distal to the RsrXl restriction site. This factor was 1.2 for the P,-P, primer combination and 1.08 for the Pl-Pl primer combination. Controls for /{pull digestion included two known clonal samples from chronic myelogenous leukemia (CML) patients whose clonal alleles were either the high or low molecular weight signals. A control for BstXl digest was a male sample known to have the BstXl polymorphism. Control DNA was digested and amplified concurrently with the test sample. Results reported here include only experiments where the controls had ratios of the clonal allele relative to the nonclonal allele of >90:10 and in which there wcrc no bands present in the negative control (no DNA added) lane.
RESULTS
Fourteen female patients with CD3-lymphoproliferative disease of granular lymphocytes were screened for heterozygosity at the X-linked loci of the PGK gene. Six heterozygous patients were identified who could be informative on clonal studies. Of these 6. 5 patients were polymorphic for the Bg/l or BsfXI restriction sites. One patient who did not have the Bg/l polymorphism had a BsfXI restriction site polymorphism. Only 2 patients were screened for the polymorphic VNTR with M278 and I was found informative.
Of these 7 patients who could be analyzed for clonality, 6 had sufficient amounts of DNA for conventional Southern analysis and I was studied by PCR-based clonal analysis. In the 6 patients studied by conventional Southern analysis, both CD3-LGLs and neutrophils could be studied (Fig 2) . In 5 ofthe 6 patients, the analysis demonstrated a polyclonal pop ulation of CD3-LGLs. In one patient, the CD3-LGLs a p peared clonal (patient no. 5). but the clonal ratio of the neutrophils in the same patient was already significantly skewed. 
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In all patients, the neutrophils appeared polyclonal. These same blots were then exposed to photostimulable storage phosphorimaging plates and then scanned to quantitate the relative intensities of the signals. Of the six patients studied with this method, the largest difference that was measured in the clonal ratios between the CD3-LGLs and the neutrophils was approximately 0. I5 (Table 3 ). This included the one patient who had a clonal pattern in the CD3-LGL cell fraction, but the neutrophils already had a significantly skewed clonal ratio so as to render this result indeterminate.
Examples of known clonal samples analyzed by this method are shown (Fig 3) .
In four patients, PCR-based clonal analysis was performed to determine clonal status (Fig 4) . Three patients had already been studied by a conventional Southem analysis above. All four of the study samples and the clonal controls were amplified by primer pairs flanking the BsfXl polymorphic restriction site and six HpuII sites in the PGK gene. The results from PCR-based clonal analyses in three patients were similar to those previously obtained from Southern analysis when the allelic signals were quantified densitometrically. PCRbased clonal analyses demonstrated that the CD3-large granular lymphocytes in patients nos. I and 2 were polyclonal and the clonal ratios determined by PCR were similar to those observed by Southern analysis. In patient five, the shift in clonal ratios seen in the Southern analysis was identified again in the LGL fraction, but the assessment ofclonal status was not possible because the clonal ratio of the neutrophils was already significantly skewed. Patient no. 7 had polyclonal patterns for both the CD3-LGL cell fraction and neutrophils, although a marked shift in the distribution of the two alleles (clonal ratio) of the CD3-LGL cell fraction in comparison with the neutrophils from that same patient was reproducibly demonstrated (Table 3) .
DISCUSSION
Lymphoproliferative disorders of granular lymphocytes are characterized by expansions of lymphocytes of a CD3-or CD3' phenotype'" with molecular characteristics suggesting different cell origins for NK cells and T cells. respectively.
Because the TCR gene dues not rearrange in CD3-lymphocytes, this cannot be used as a marker in lymphoproliferative disorders of granular lymphocytes of this type and therefore X-linked markers must be used. If X-linked markers are used to study clonality, cell populations of interest need to be highly purified. Oligoclonal proliferations or small populations of clonal outgrowth may not be detected. In this study using purified cell populations, six of the seven patients with CD3-lymphoproliferative disorder of granular lymphocytes could not be demonstrated to be clonal. One patient had a clonal status that was indeterminate.
Clonal cytogenetic abnormalities in patients with CD3-LDGL have been documented in several reports, primarily from Japan, supporting a neoplastic disorder in these patient~.'~-'* The aggressive course and clinical features such as lymphadenopathy, skin infiltrations, ascites, and central nervous system involvement observed in CD3-Japanese patients with LDGL differ markedly from those reported in CD3-patients with LDGL from the United States and Europe. A role of EBV in the malignant transformation was supported by showing clonal integration of EBV DNA into CD3-LGL of these Japanese patients. 23 In contrast, we have not found EBV DNA in cells from our patients with CD3-LDGL by Southern blot hybridization anal~ses.2~~ These differences in clonal evaluation between the patients in the study and those from Japan may reflect clinical heterogenicity of CD3-LDGL, perhaps resulting from different mechanisms of pathogenesis.
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From In three of our patients (nos. 2, 5, and 7), there were differences in the clonal ratios between the CD3-LGL fraction and the neutrophils. The observations might be explained in several ways. The first possible explanation is the inherent variance in any analysis ofthis type based on technical factors. However, these differences were reproducible when the analysis was repeated and also were seen when clonal analysis was done by both Southern transfer of restrictiondigested genomic DNA or by PCR amplification. The second possibility is that there may be constitutional difference in the clonal ratios of different tissues from the same indi~idual.'~ Third, the change in the clonal ratio is consistent with the possibility that there is a small clonal population within the LGL fraction contributing to the observed change or that there is an oligoclonal origin of CD3-LGDL? The determination of whether there may be clonal subpopulation of CD3-LGL will depend on the development of more specific clonal markers of NK cells.
Our study demonstrated that the majority of the patients did not have evidence for clonal proliferation of CD3-LGL; moreover, an aggressive clinical course has not been observed in any of our patients. Because the number of patients studied in this report is relatively small, it is possible that these results may not be representative of all cases of chronic CD3-LDGL.
Nevertheless, these findings would support a reactive rather than a neoplastic nature of the lymphocytosis in contrast to the clonal nature of CD3' LDGL (LGL leukemia). However, it is conceivable that such a polyclonal or oligoclonal LGL For personal use only. on November 16, 2017. by guest www.bloodjournal.org From
